# Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial

> **NCT01968850** · PHASE2 · COMPLETED · sponsor: **Unity Health Toronto** · enrollment: 30 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** alendronate/vitamin D

## Key facts

- **NCT ID:** NCT01968850
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-23
- **Primary completion:** 2018-03-19
- **Final completion:** 2018-03-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968850, "Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01968850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*